Cash flow Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-09-18 EDT			5-day change	1st Jan Change
882.20 ^DKK	-2.35%		-0.93%	+26.37%

09-18	Hims & Hers offers compounded Wegovy for $99 a month to select professions	RE
09-18	NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases	CI

f343217c12c480.jcOnZEbC18326WaveGRUgBGnqmng-nRVq_4sde___r0.6oyTDn6ImYSgjlXaDgEZ72LK7wPXuBcQ75NEHbWSuP-9rO0BcbLlhIHEIw

Published financial data: NOVO NORDISK A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	122B	127B	141B	177B	232B
Total Revenues	122B	127B	141B	177B	232B
Cost of Goods Sold, Total	19.56B	20.93B	23.66B	28.45B	35.76B
Gross Profit	102B	106B	117B	149B	196B
Selling General & Admin Expenses, Total	35.83B	36.89B	41.06B	50.68B	61.6B
R&D Expenses	13.77B	15.11B	17.2B	23.29B	31.03B
Other Operating Expenses	-600M	-460M	-456M	-1.08B	-119M
Other Operating Expenses, Total	49B	51.54B	57.8B	72.89B	92.51B
Operating Income	53.46B	54.48B	59.34B	75.62B	104B
Interest Expense, Total	-220M	-390M	-289M	-378M	-542M
Interest And Investment Income	65M	337M	231M	239M	1.07B
Net Interest Expenses	-155M	-53M	-58M	-139M	527M
Income (Loss) On Equity Invest.	-137M	149M	-24M	-189M	81M
Currency Exchange Gains (Loss)	-3.21B	-747M	344M	-4.65B	1.65B
Other Non Operating Income (Expenses)	-281M	-150M	-122M	-181M	-197M
EBT, Excl. Unusual Items	49.68B	53.68B	59.48B	70.46B	106B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-124M	-51M	-
Gain (Loss) On Sale Of Investments	-145M	-195M	296M	-587M	37M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-979M	-350M	-573M	-760M	-1.41B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	48.55B	53.13B	59.08B	69.06B	105B
Income Tax Expense	9.6B	10.99B	11.32B	13.54B	20.99B
Earnings From Continuing Operations	38.95B	42.14B	47.76B	55.52B	83.68B
Net Income to Company	38.95B	42.14B	47.76B	55.52B	83.68B
Net Income - (IS)	38.95B	42.14B	47.76B	55.52B	83.68B
Net Income to Common Incl Extra Items	38.95B	42.14B	47.76B	55.52B	83.68B
Net Income to Common Excl. Extra Items	38.95B	42.14B	47.76B	55.52B	83.68B
Per Share Items
Net EPS - Basic	8.2	9.03	10.4	12.26	18.67
Basic EPS - Continuing Operations	8.2	9.03	10.4	12.26	18.67
Basic Weighted Average Shares Outstanding	4.75B	4.67B	4.59B	4.53B	4.48B
Net EPS - Diluted	8.19	9	10.37	12.22	18.62
Diluted EPS - Continuing Operations	8.19	9	10.37	12.22	18.62
Diluted Weighted Average Shares Outstanding	4.76B	4.68B	4.61B	4.54B	4.49B
Normalized Basic EPS	6.54	7.19	8.09	9.72	14.79
Normalized Diluted EPS	6.53	7.17	8.07	9.69	14.75
Dividend Per Share	4.18	4.55	5.2	6.2	9.4
Payout Ratio	49.83	47.75	45.06	45.57	37.96
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	57.07B	58.79B	63.55B	80.93B	110B
EBITA	53.95B	55.57B	60.21B	77.02B	106B
EBIT	53.46B	54.48B	59.34B	75.62B	104B
EBITDAR	57.44B	59.1B	64.86B	82.42B	112B
Effective Tax Rate - (Ratio)	19.78	20.69	19.17	19.6	20.05
Total Current Taxes	11.08B	10.99B	13.27B	18.17B	25B
Total Deferred Taxes	-1.48B	-2M	-1.94B	-4.63B	-4.01B
Normalized Net Income	31.05B	33.55B	37.18B	44.04B	66.28B
Interest on Long-Term Debt	108M	97M	-	-	-
Non-Cash Pension Expense	151M	138M	139M	185M	126M
Supplemental Operating Expense Items
Selling and Marketing Expenses	31.82B	32.93B	37.01B	46.22B	56.74B
General and Administrative Expenses	4.01B	3.96B	4.05B	4.47B	4.86B
Research And Development Expense From Footnotes	14.22B	15.46B	17.77B	24.05B	32.44B
Net Rental Expense, Total	377M	312M	1.3B	1.49B	1.83B
Imputed Operating Lease Interest Expense	266M	131M	163M	172M	301M
Imputed Operating Lease Depreciation	111M	181M	1.14B	1.32B	1.53B
Stock-Based Comp., Other (Total)	363M	823M	1.04B	1.54B	2.15B
Total Stock-Based Compensation	363M	823M	1.04B	1.54B	2.15B

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	15.48B	12.76B	10.72B	12.65B	14.39B
Short Term Investments	-	-	6.76B	10.92B	15.84B
Total Cash And Short Term Investments	15.48B	12.76B	17.48B	23.57B	30.23B
Accounts Receivable, Total	24.91B	27.73B	40.64B	50.56B	64.77B
Other Receivables	4.24B	4.45B	6.16B	6.94B	10.49B
Total Receivables	29.15B	32.18B	46.8B	57.5B	75.26B
Inventory	17.64B	18.54B	19.62B	24.39B	31.81B
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	188M	2.33B	1.69B	2.73B	2.34B
Total Current Assets	62.46B	65.81B	85.6B	108B	140B
Gross Property Plant And Equipment	84.42B	86.69B	95.89B	111B	139B
Accumulated Depreciation	-33.87B	-36.42B	-40.52B	-44.76B	-47.62B
Net Property Plant And Equipment	50.55B	50.27B	55.36B	66.67B	90.96B
Long-term Investments	1.81B	1.65B	1.44B	1.34B	1.66B
Goodwill	-	-	4.35B	5.09B	4.46B
Other Intangibles, Total	5.84B	20.66B	38.82B	46.32B	55.94B
Deferred Tax Assets Long-Term	4.12B	5.86B	8.67B	13.43B	20.38B
Other Long-Term Assets, Total	841M	674M	267M	206M	1.43B
Total Assets	126B	145B	195B	241B	314B
Liabilities
Accounts Payable, Total	6.36B	5.72B	8.87B	15.59B	25.61B
Accrued Expenses, Total	30.33B	33.75B	50.57B	69.18B	99.43B
Short-term Borrowings	659M	6.68B	12.86B	480M	456M
Current Portion of Long-Term Debt	-	-	-	-	4.85B
Current Portion of Leases	815M	775M	822M	986M	1.17B
Current Income Taxes Payable	4.21B	3.91B	3.66B	7.09B	7.12B
Other Current Liabilities	16.61B	19.43B	22.74B	27.62B	31.03B
Total Current Liabilities	58.98B	70.27B	99.52B	121B	170B
Long-Term Debt	-	-	9.65B	20.78B	15.98B
Long-Term Leases	3.01B	2.9B	3.31B	3.54B	4.55B
Pension & Other Post Retirement Benefits	1.33B	1.4B	1.28B	762M	742M
Deferred Tax Liability Non Current	80M	2.5B	5.27B	7.06B	10.16B
Other Non Current Liabilities	4.61B	4.53B	4.73B	4.69B	6.84B
Total Liabilities	68.02B	81.6B	124B	158B	208B
Common Stock, Total	480M	470M	462M	456M	451M
Retained Earnings	57.82B	63.77B	72B	80.59B	105B
Treasury Stock	-10M	-8M	-6M	-6M	-5M
Comprehensive Income and Other	-694M	-911M	-1.71B	2.45B	1.28B
Total Common Equity	57.59B	63.32B	70.75B	83.49B	107B
Total Equity	57.59B	63.32B	70.75B	83.49B	107B
Total Liabilities And Equity	126B	145B	195B	241B	314B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.7B	4.62B	4.56B	4.5B	4.46B
ECS Total Common Shares Outstanding	4.7B	4.62B	4.56B	4.5B	4.46B
Book Value / Share	12.24	13.69	15.52	18.55	23.9
Tangible Book Value	51.76B	42.67B	27.58B	32.07B	46.16B
Tangible Book Value Per Share	11	9.23	6.05	7.13	10.35
Total Debt	4.48B	10.36B	26.64B	25.78B	27.01B
Net Debt	-10.99B	-2.4B	9.16B	2.21B	-3.22B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.33B	1.4B	-	-	-
Debt Equivalent Oper. Leases	3.02B	2.5B	10.42B	11.93B	14.66B
Equity Method Investments, Total	474M	582M	525M	327M	410M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	2.84B	3.33B	4.31B	6.39B	9.5B
Inventories - Work In Process, Total	11.38B	12.25B	12.28B	13.67B	17.6B
Inventories - Finished Goods, Total	4.85B	5.11B	5.28B	6.04B	7.22B
Land - (BS)	30.26B	37.51B	41.08B	43.4B	48.99B
Machinery, Total	33.81B	38.38B	43.72B	45.66B	49.93B
Full Time Employees	42.7K	44.72K	47.79K	54.39K	63.37K
Part Time Employees	555	600	686	792	949
Accumulated Allowance for Doubtful Accounts (Supple)	1.48B	1.38B	1.43B	1.52B	1.79B

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	38.95B	42.14B	47.76B	55.52B	83.68B
Depreciation & Amortization - CF	3.97B	4.18B	4.24B	4.95B	5.46B
Amortization of Goodwill and Intangible Assets - (CF)	487M	1.1B	866M	1.4B	1.62B
Depreciation & Amortization, Total	4.46B	5.28B	5.11B	6.36B	7.08B
Amortization of Deferred Charges, Total - (CF)	-	-	200M	195M	213M
(Gain) Loss From Sale Of Asset	-68M	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	145M	195M	-340M	124M	-
Asset Writedown & Restructuring Costs	1.2B	477M	714M	809M	2.12B
(Income) Loss On Equity Investments - (CF)	137M	-149M	24M	189M	-
Stock-Based Compensation (CF)	363M	823M	1.04B	1.54B	-
Other Operating Activities, Total	4.98B	7.54B	9.15B	19.48B	28.06B
Change In Accounts Receivable	-2.13B	-2.82B	-12.91B	-9.92B	-14.21B
Change In Inventories	-1.3B	-895M	-1.08B	-4.77B	-7.42B
Change In Accounts Payable	-398M	-641M	3.15B	6.72B	10.02B
Change in Other Net Operating Assets	441M	5M	2.18B	2.63B	-631M
Cash from Operations	46.78B	51.95B	55B	78.89B	109B
Capital Expenditure	-8.93B	-5.82B	-6.34B	-12.15B	-25.81B
Sale of Property, Plant, and Equipment	4M	7M	-	-	-
Cash Acquisitions	-	-	-18.28B	-7.08B	-
Divestitures	-3M	-	-	-	-
Sale (Purchase) of Intangible assets	-2.3B	-16.26B	-1.05B	-2.61B	-13.09B
Investment in Marketable and Equity Securities, Total	-299M	-380M	-5.94B	-3.09B	-5B
Other Investing Activities, Total	20M	18M	4M	-	-
Cash from Investing	-11.51B	-22.44B	-31.6B	-24.92B	-43.89B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	5.68B	22.16B	11.22B	-
Total Debt Issued	-	5.68B	22.16B	11.22B	-
Long-Term Debt Repaid, Total	-741M	-950M	-6.69B	-13.62B	-1.47B
Total Debt Repaid	-741M	-950M	-6.69B	-13.62B	-1.47B
Repurchase of Common Stock	-15.33B	-16.86B	-19.45B	-24.09B	-29.92B
Common Dividends Paid	-19.41B	-20.12B	-21.52B	-25.3B	-31.77B
Common & Preferred Stock Dividends Paid	-19.41B	-20.12B	-21.52B	-25.3B	-31.77B
Cash from Financing	-35.48B	-32.24B	-25.49B	-51.8B	-63.16B
Foreign Exchange Rate Adjustments	-7M	-456M	591M	-238M	-119M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-218M	-3.18B	-1.51B	1.93B	1.74B
Supplemental Items
Cash Interest Paid	204M	422M	261M	272M	491M
Cash Income Tax Paid (Refund)	10.94B	10.11B	14.44B	14.52B	25.9B
Levered Free Cash Flow	27.17B	17.06B	43.83B	57.5B	54.1B
Unlevered Free Cash Flow	27.31B	17.3B	44.01B	57.73B	54.44B
Change In Net Working Capital	-308M	766M	-7.96B	-17.13B	-18.91B
Net Debt Issued / Repaid	-741M	4.73B	15.47B	-2.41B	-1.47B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	28.27	25.17	21.85	21.69	23.39
Return on Total Capital	58.4	50.16	43.36	45.74	53.53
Return On Equity %	71.19	69.7	71.24	72	88.07
Return on Common Equity	71.19	69.7	71.24	72	88.07
Margin Analysis
Gross Profit Margin %	83.97	83.51	83.2	83.92	84.6
SG&A Margin	29.36	29.06	29.16	28.64	26.52
EBITDA Margin %	46.77	46.31	45.14	45.73	47.28
EBITA Margin %	44.21	43.78	42.76	43.53	45.47
EBIT Margin %	43.81	42.91	42.15	42.73	44.77
Income From Continuing Operations Margin %	31.92	33.19	33.92	31.38	36.03
Net Income Margin %	31.92	33.19	33.92	31.38	36.03
Net Avail. For Common Margin %	31.92	33.19	33.92	31.38	36.03
Normalized Net Income Margin	25.44	26.43	26.4	24.89	28.54
Levered Free Cash Flow Margin	22.27	13.44	31.13	32.49	23.29
Unlevered Free Cash Flow Margin	22.38	13.63	31.26	32.63	23.44
Asset Turnover
Asset Turnover	1.03	0.94	0.83	0.81	0.84
Fixed Assets Turnover	2.64	2.52	2.67	2.9	2.95
Receivables Turnover (Average Receivables)	5.12	4.82	4.12	3.88	4.03
Inventory Turnover (Average Inventory)	1.15	1.16	1.24	1.29	1.27
Short Term Liquidity
Current Ratio	1.06	0.94	0.86	0.89	0.82
Quick Ratio